COLD AGGLUTININ DISEASE
Clinical trials for COLD AGGLUTININ DISEASE explained in plain language.
Never miss a new study
Get alerted when new COLD AGGLUTININ DISEASE trials appear
Sign up with your email to follow new studies for COLD AGGLUTININ DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare blood disorder
Disease control CompletedThis study tested whether a drug called pegcetacoplan could help people with cold agglutinin disease, a rare condition where the immune system attacks red blood cells. Twenty-four adults with the disease received either the drug or a placebo via twice-weekly injections at home fo…
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC
-
Rare blood disease patients get lifeline drug in japan
Disease control CompletedThis study provided continued access to the drug sutimlimab for Japanese adults with cold agglutinin disease (CAD) who had benefited from it in previous clinical trials. The goal was to allow these patients to keep receiving the treatment until it became commercially available in…
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC